The list of miRs as predictive biomarkers of response to vascular endothelial growth factor- or epidermal growth factor receptor (EGFR)-targeted therapy and chemotherapy, which are used in the standard treatment regimen for CRC, is shown in Table 3. Here, EGFR is linked to colorectal carcinoma.